NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Mendelics Análise Genômica

Mendelics Análise Genômica

Private
São PauloHealthcare & Life Scienceshttps://mendelics.com.br/

Last Round

Debt

Apr 10, 2026

Est. Valuation

$120.31M

Total Funding Raised

$22.33M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mendelics Análise Genômica is a biotechnology company that provides genomic diagnostic services for rare diseases and cancer using next-generation sequencing technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical genomicsgenetic testingwhole exome sequencingwhole genome sequencingbioinformaticsprecision medicinerare disease diagnosispharmacogenomicsgenetic panelsmedical AIdiagnostic laboratorygenomic analysisDNA testingvariant callingbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mendelics Análise Genômica Comparables

Compare Mendelics Análise Genômica with similar companies based on industry and business-model similarity.

Mendelics Análise Genômica comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NeoGenômica
80%
CENTOGENE
78%
Fleury S.A.
76%

Mendelics Análise Genômica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtApr 10, 2026
Series B ExtensionOct 19, 2023
Series BNov 26, 2019
Series ADec 1, 2014

Key People

Founding team and executive leadership

David Schlesinger

CEO & Co-founder

Founding Team

Mendelics Análise Genômica Investors

Notable investors and investment history

Mendelics Análise Genômica investors
InvestorRounds
National Bank for Economic and Social DevelopmentDebt
FinHealth Gestão de RecursosSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2026

    $9.55M debt round led by National Bank for Economic and Social Development.

Mendelics Análise Genômica Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mendelics Análise Genômica Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mendelics Análise Genômica's valuation, stock price, and market status.

Firmographic Details

HeadquartersSão Paulo
Employee Range152
Year Founded2012
Last FundingApr 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.